Juan José Peña Deudero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Juan José Peña Deudero has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
Carlos Caramelo
Laboratory of Nephrology and Hypertension, Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid - Spain; Dialysis Unit, Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid - Spain
11 shared publicationsFernando Neria
Laboratory of Nephrology and Hypertension, Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid - Spain
6 shared publicationsFrancisco R. González-Pacheco
Laboratory of Nephrology and Hypertension, Jiménez Díaz-Capio Fundation, Universidad Autónoma de Madrid, Queen Sophie Renal Research Institute, Madrid - Spain
5 shared publications- Amanda Sierra
Achucarro Basque Center for Neuroscience
4 shared publications Susana Yagüe
4 shared publications- Alberto Ortiz
Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM , Madrid
3 shared publications
Latest Publications
- Open Access
- 3 October 2017
- Published by Springer Nature in BMC Systems Biology
- Vol. 11 (S5) , 90-102
Multitype Bellman-Harris branching model provides biological predictors of early stages of adult hippocampal neurogenesis
Adult hippocampal neurogenesis, the process of formation of new neurons, occurs throughout life in the hippocampus. New neurons have been associated with learning and memory as well as mood control, and impaired neurogenesis has been linked to depression, schizophrenia, autism and cognitive decline during aging. Thus, understanding the biological properties of adult neurogenesis has important implications for human health. Computational models of neurogenesis have attempted to derive biologically relevant knowledge, hard to achieve using experimentation. However, the majority of the computational studies have predominantly focused on the late stages of neurogenesis, when newborn neurons integrate into hippocampal circuitry. Little is known about the early stages that regulate proliferation, differentiation, and survival of neural stem cells and their immediate progeny. Here, based on the branching process theory and biological evidence, we developed a computational model that represents the early stage hippocampal neurogenic cascade and allows prediction of the overall efficiency of neurogenesis in both normal and diseased conditions. Using this stochastic model with a simulation program, we derived the equilibrium distribution of cell population and simulated the progression of the neurogenic cascade. Using BrdU pulse-and-chase experiment to label proliferating cells and their progeny in vivo, we quantified labeled newborn cells and fit the model on the experimental data. Our simulation results reveal unknown but meaningful biological parameters, among which the most critical ones are apoptotic rates at different stages of the neurogenic cascade: apoptotic rates reach maximum at the stage of neuroblasts; the probability of neuroprogenitor cell renewal is low; the neuroblast stage has the highest temporal variance within the cell types of the neurogenic cascade, while the apoptotic stage is short. At a practical level, the stochastic model and simulation framework we developed will enable us to predict overall efficiency of hippocampal neurogenesis in both normal and diseased conditions. It can also generate predictions of the behavior of the neurogenic system under perturbations such as increase or decrease of apoptosis due to disease or treatment.
- 3 October 2017
- Published by Springer Nature in BMC Systems Biology
- Vol. 11 (S5) , 90-102
Open AccessMultitype Bellman-Harris branching model provides biological predictors of early stages of adult hippocampal neurogenesis
Adult hippocampal neurogenesis, the process of formation of new neurons, occurs throughout life in the hippocampus. New neurons have been associated with learning and memory as well as mood control, and impaired neurogenesis has been linked to depression, schizophrenia, autism and cognitive decline during aging. Thus, understanding the biological properties of adult neurogenesis has important implications for human health. Computational models of neurogenesis have attempted to derive biologically relevant knowledge, hard to achieve using experimentation. However, the majority of the computational studies have predominantly focused on the late stages of neurogenesis, when newborn neurons integrate into hippocampal circuitry. Little is known about the early stages that regulate proliferation, differentiation, and survival of neural stem cells and their immediate progeny. Here, based on the branching process theory and biological evidence, we developed a computational model that represents the early stage hippocampal neurogenic cascade and allows prediction of the overall efficiency of neurogenesis in both normal and diseased conditions. Using this stochastic model with a simulation program, we derived the equilibrium distribution of cell population and simulated the progression of the neurogenic cascade. Using BrdU pulse-and-chase experiment to label proliferating cells and their progeny in vivo, we quantified labeled newborn cells and fit the model on the experimental data. Our simulation results reveal unknown but meaningful biological parameters, among which the most critical ones are apoptotic rates at different stages of the neurogenic cascade: apoptotic rates reach maximum at the stage of neuroblasts; the probability of neuroprogenitor cell renewal is low; the neuroblast stage has the highest temporal variance within the cell types of the neurogenic cascade, while the apoptotic stage is short. At a practical level, the stochastic model and simulation framework we developed will enable us to predict overall efficiency of hippocampal neurogenesis in both normal and diseased conditions. It can also generate predictions of the behavior of the neurogenic system under perturbations such as increase or decrease of apoptosis due to disease or treatment.
- Open Access
- 20 September 2016
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 14 (9) , e1002554
Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling
[This corrects the article DOI: 10.1371/journal.pbio.1002466.].
- 20 September 2016
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 14 (9) , e1002554
Open AccessCorrection: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling
[This corrects the article DOI: 10.1371/journal.pbio.1002466.].
- Top Cited Papers
- 1 May 2015
- Published by Elsevier in Cell Stem Cell
- Vol. 16 (5) , 488-503
Neuronal Hyperactivity Accelerates Depletion of Neural Stem Cells and Impairs Hippocampal Neurogenesis
- 1 May 2015
- Published by Elsevier in Cell Stem Cell
- Vol. 16 (5) , 488-503
Top Cited PapersNeuronal Hyperactivity Accelerates Depletion of Neural Stem Cells and Impairs Hippocampal Neurogenesis
- 1 July 2012
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 19 (23) , 4014-4023
AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation
AG490 is a tyrphostin originally described as a Janus Activated Kinase (JAK) 2 inhibitor. AG490 also inhibits epidermal growth factor receptor (EGFR) and guanylyl cyclases (GC). More recently, AG490 was associated with oxidative stress protection in experimental acute kidney injury models. We now show that AG490 is also a strong activator of the Hypoxia Inducible Factor (HIF)-1. Under normoxic conditions HIF-1α is degraded through hydroxylation, von Hippel Lindau protein (VHL)-mediated ubiquitin tagging and proteasomal degradation. AG490 increased HIF-1α protein, but not HIF-1α mRNA levels, dose- and time-dependently in cultured endothelial, vascular smooth muscle and kidney proximal tubular epithelial cells. AG490 increased HIF-1α protein half-life, suggesting that HIF-1α protein accumulation resulted from a decreased degradation. In this regard, AG490 prevented HIF-1α hydroxylation and increased HIF-1α protein levels in human renal carcinoma cells expressing VHL, but did not further increase HIF-1α in VHL negative cells. AG490 did not prevent the proteasomal degradation of other proteins. HIF-1α was not upregulated by dominant negative JAK2constructs, tyrphostin AG9, the EGFR inhibitors erbstatin and genistein, the GC inhibitor Ly83583 or cGMP analogues. Finally, AG490 also increased HIF-1α transcriptional activity evidenced by the increased HIF-1α-dependent VEGF expression. In conclusion, AG490 is a novel HIF-1α activator that increases HIF-1α half-life and protein levels through interference with HIF-1α hydroxylation and VHL-mediated degradation. This action may contribute to the cell and tissue protective effects of AG490.
- 1 July 2012
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 19 (23) , 4014-4023
AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation
AG490 is a tyrphostin originally described as a Janus Activated Kinase (JAK) 2 inhibitor. AG490 also inhibits epidermal growth factor receptor (EGFR) and guanylyl cyclases (GC). More recently, AG490 was associated with oxidative stress protection in experimental acute kidney injury models. We now show that AG490 is also a strong activator of the Hypoxia Inducible Factor (HIF)-1. Under normoxic conditions HIF-1α is degraded through hydroxylation, von Hippel Lindau protein (VHL)-mediated ubiquitin tagging and proteasomal degradation. AG490 increased HIF-1α protein, but not HIF-1α mRNA levels, dose- and time-dependently in cultured endothelial, vascular smooth muscle and kidney proximal tubular epithelial cells. AG490 increased HIF-1α protein half-life, suggesting that HIF-1α protein accumulation resulted from a decreased degradation. In this regard, AG490 prevented HIF-1α hydroxylation and increased HIF-1α protein levels in human renal carcinoma cells expressing VHL, but did not further increase HIF-1α in VHL negative cells. AG490 did not prevent the proteasomal degradation of other proteins. HIF-1α was not upregulated by dominant negative JAK2constructs, tyrphostin AG9, the EGFR inhibitors erbstatin and genistein, the GC inhibitor Ly83583 or cGMP analogues. Finally, AG490 also increased HIF-1α transcriptional activity evidenced by the increased HIF-1α-dependent VEGF expression. In conclusion, AG490 is a novel HIF-1α activator that increases HIF-1α half-life and protein levels through interference with HIF-1α hydroxylation and VHL-mediated degradation. This action may contribute to the cell and tissue protective effects of AG490.
- Top Cited Papers
- 1 October 2010
- Published by Elsevier in Cell Stem Cell
- Vol. 7 (4) , 483-495
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
- 1 October 2010
- Published by Elsevier in Cell Stem Cell
- Vol. 7 (4) , 483-495
Top Cited PapersMicroglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
- 1 September 2009
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 22 (5) , 647-653
Alkalinization potentiates vascular calcium deposition in an uremic milieu
Background: Vascular calcification is a serious complication of chronic kidney disease. Acid-base balance is a relevant, albeit somewhat forgotten factor in the regulation of calcium deposition. Hemodialysis patients undergo repeated episodes of alkaline loading from the dialysate, resulting in prolonged alkalinization. We have hypothesized that extracellular alkalinization may promote vascular calcification. Methods: Primary cultures of vascular smooth muscle cells (VSMCs) were induced to calcify by the phosphate donor β-glycerophosphate, in the presence of normal or uremic sera from hemodialysis patients and at different pH conditions. The influence of sodium bicarbonate supplementation for 2 months on aorta calcification was studied in uremic rats. Results: Uremic serum increased vascular smooth muscle cell calcification (twofold over nonuremic human serum at day 12, pConclusions: Extracellular alkalinization promotes vascular calcification in vitro and in vivo. These findings suggest that the control of metabolic alkalosis should be considered as part of the strategy to prevent vascular calcification in patients with chronic kidney disease.
- 1 September 2009
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 22 (5) , 647-653
Alkalinization potentiates vascular calcium deposition in an uremic milieu
Background: Vascular calcification is a serious complication of chronic kidney disease. Acid-base balance is a relevant, albeit somewhat forgotten factor in the regulation of calcium deposition. Hemodialysis patients undergo repeated episodes of alkaline loading from the dialysate, resulting in prolonged alkalinization. We have hypothesized that extracellular alkalinization may promote vascular calcification. Methods: Primary cultures of vascular smooth muscle cells (VSMCs) were induced to calcify by the phosphate donor β-glycerophosphate, in the presence of normal or uremic sera from hemodialysis patients and at different pH conditions. The influence of sodium bicarbonate supplementation for 2 months on aorta calcification was studied in uremic rats. Results: Uremic serum increased vascular smooth muscle cell calcification (twofold over nonuremic human serum at day 12, pConclusions: Extracellular alkalinization promotes vascular calcification in vitro and in vivo. These findings suggest that the control of metabolic alkalosis should be considered as part of the strategy to prevent vascular calcification in patients with chronic kidney disease.
- Open Access
- 1 January 2009
- Published by Elsevier in Kidney International
- Vol. 75 (2) , 227-234
Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity
- 1 January 2009
- Published by Elsevier in Kidney International
- Vol. 75 (2) , 227-234
Open AccessInhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity
- Open Access
- 1 April 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (17) , 11435-11444
Induction of Hypoxia-inducible Factor 1α Gene Expression by Vascular Endothelial Growth Factor
- 1 April 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (17) , 11435-11444
Open AccessInduction of Hypoxia-inducible Factor 1α Gene Expression by Vascular Endothelial Growth Factor
- 30 August 2007
- Vol. 22 (2)
Some insight into the vascular endothelia growth factor/erythropoietin relationship.
- 30 August 2007
- Vol. 22 (2)
Some insight into the vascular endothelia growth factor/erythropoietin relationship.